AMGN Amgen Earnings and EPS analysis

EPS in 2026 (TTM): $14.48

Last Report Period Date: Mar 31, 2026

As of June 2026, AMGN's current EPS stands at $14.48, according to the latest financial reports. For the year 2025, the company recorded an earnings per share (EPS) of $14.33, which marks an increase compared to its EPS of $7.62 in 2024. AMGN reported an EPS of $3.37 for the quarterly report ending on Mar 31, 2026.

For 2025, Amgen's EPS was $14.33, an increase of 88.1% from $7.62 in 2024. For the fiscal quarter that ended on Mar 31, 2026, the per-share earnings was $3.37, showing a 4.7% increase from the same quarter last year. For the twelve months ending March 2026, the EPS is $14.48. For the year 2024, the yearly earnings per share was $7.62, marking a decrease of 39.3% from 2023.

Amgen has registered an increase in EPS of 4.7% during the last 12 months (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of 5.6% per year for the last three years. Amgen had an average annual EPS growth rate of 2.9% during the last 5 years. A 10-year view shows that AMGN has seen an average EPS growth of 4.6% per year.